Condition
Non-Muscle Invasive Bladder Urothelial Carcinoma clinical trials and research
Research outlook What's coming for Bladder cancer: the next 6 months to 5 yearsAs of November 12, 2026, Find a Trial lists 7 Non-Muscle Invasive Bladder Urothelial Carcinoma clinical trials that are recruiting, at sites in 4 countries (most in United States (4), Italy (2), Canada (1)). By phase: Phase 1 (2), Phase 2 (2), Phase 4 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 7Clinical trials
- 4Countries
Newest Non-Muscle Invasive Bladder Urothelial Carcinoma clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Combining pembrolizumab with radiation therapy for bladder cancer treatment | Phase 2 | Tucson, Arizona and 146 other locations | Recruiting | Jan 13, 2025 |
| Combining irinotecan liposomes and epirubicin for bladder cancer treatment after anthracyclines failure | Phase 1 | Chongqing | Recruiting | Jan 9, 2025 |
| Combining Durvalumab and Monalizumab for Bladder Cancer Treatment | Phase 2 | San Francisco, California and 4 other locations | Recruiting | Jul 16, 2024 |
| Improving tumor detection before bladder cancer surgery | — | Omaha, Nebraska and 1 other locations | Recruiting | May 2, 2024 |
| Tracking quality of life and relapses in bladder cancer patients after surgery | — | Milan, MI | Recruiting | Dec 12, 2023 |
| MRI (VI-RADS) plus photodynamic-guided TURBT to avoid routine repeat bladder resections | Phase 4 | Rome, Lazio | Recruiting | Jul 27, 2023 |
| Bicalutamide for non-muscle invasive bladder cancer | Phase 1 | Tucson, Arizona and 5 other locations | Recruiting | Aug 30, 2022 |
All recruiting trials (7)
-
Combining pembrolizumab with radiation therapy for bladder cancer treatment
This study is testing if combining the immunotherapy drug pembrolizumab with radiation therapy can help people with non-muscle invasive bladder cancer do better than standard chemotherapy during treatment.
-
Combining irinotecan liposomes and epirubicin for bladder cancer treatment after anthracyclines failure
This study is testing a new treatment that combines two drugs, irinotecan liposomes and epirubicin, to see if it can help people with bladder cancer who didn't get better with previous therapy.
-
Combining Durvalumab and Monalizumab for Bladder Cancer Treatment
This study is testing a combination of two drugs, durvalumab and monalizumab, to see if they can help people with certain types of bladder cancer that haven't responded to standard treatment.
-
Improving tumor detection before bladder cancer surgery
This study is testing a new combination of tests to see if they can accurately find leftover tumors in bladder cancer patients before they have surgery.
-
Tracking quality of life and relapses in bladder cancer patients after surgery
This study is tracking how bladder cancer patients feel and whether their cancer comes back after surgery over the next 10 years.
-
MRI (VI-RADS) plus photodynamic-guided TURBT to avoid routine repeat bladder resections
This study tests whether using a preoperative MRI VI-RADS score together with photodynamic-assisted TURBT can let people with non-muscle-invasive bladder cancer safely skip a routine second resection.
-
Bicalutamide for non-muscle invasive bladder cancer
This trial tests whether the anti-androgen drug bicalutamide changes EGFR protein expression in adult men with non-muscle invasive bladder cancer.
Related topics
Quick answers
How many Non-Muscle Invasive Bladder Urothelial Carcinoma clinical trials are recruiting right now?
7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in United States (4 trials), Italy (2 trials), Canada (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2, Phase 2: 2, Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.